A Link between Vitamin K and COVID-19 Results
Research that has gotten conducted suggests a connection between vitamin K low levels and the tissue fiber breakdown acceleration, which includes elastin. It is a protein component that’s involved with pulmonary diseases. A studied link is displayed between patients with better levels of vitamin K when they are infected with COVID-19. The results have shown that they will have an improved health outcome sooner than those who have an inferior status of vitamin K.
COVID-19 patients who have severe symptoms are more likely to get occurring diseases such as Type 2 diabetes, cardiovascular diseases (CVD), or hypertension that get associated with the reduction of vitamin K in the body. The findings that were conducted suggested that an improvement in vitamin K levels may get to play a significant role in the genetic development of the body’s ability to cope with the coronavirus. The studies are, however, inconclusive hence cannot be drawn to be fully warranted as right. Let’s be clear though, vitamin supplements can’t be used to cure COVID-19, and no anti-virus has been found yet.
Researchers also found a connection between COVID-19 patients who had severe symptoms and coagulopathy, a bleeding condition. The ability of the blood gets impaired to form clots. Such patients also get to suffer from thromboembolism, which involves clots of the blood in blood vessels as blocks. Vitamin K can coagulate blood by promoting and dissolving blood clots.
The vitamin K2 connection
Vitamin K2 could be linked to better health outcomes when it comes to COVID-19 cases because it has an integral part in the activation and binding role of calcium to the bones. It also can keep the calcium from getting to the walls of blood vessels and accumulating there hence causing atherosclerosis of the arteries getting hardened. Such a process is usually risky, and it’s considered to be a cardio killer. Vitamin K also has natural cheese and natto, a fermented soy dish, and research shows its high consumption probably causes fewer incidences of COVID-19 cases and other diseases.
An interesting fact that was found during the research is that the measurement of vitamin K gets determined by the inactive amount of vitamin K-dependent protein, which is called the Matrix Gla Protein. It activates the supplement. The comprehensive study concluded the most common brands used include MenaQ-7 owned by NattoPharma, a private vitamin supplement manufacturer, and its sponsored by 19 published studies of the brand’s vitamin K2.
MGP vitamin K-dependent has generally gotten accepted according to a study of an inhibitor of vascular calcification. The scientific leads of MGP suggest that it plays a significant role in the creation of lung fibrosis. It crucially offers protection of the elastic fibers against fibrosis or mineralization that gets presented in the patients’ lung that has COVID-19. When someone has low DP-ucMGP levels, they are most likely to have a significant desmosine level, which is a measure of elastic breakdown, and it’s an essential factor when it comes to pulmonary health.
Conclusion
Conclusively, the vitamin status in COVID-19 patients is reduced, and it’s related to poor prognosis. The significant lower amounts to patients with co-morbidities can’t be compared to those who don’t have any health issues. There is also degradation in the acceleration of elastin, and it means COVID-19 patients have a reduced amount of Vitamin K when associated with severe diseases.